Barbara Bedogni

University of Miami — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

30h-index2.9kcitations90works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Melanoma and MAPK Pathways(39), Cell Adhesion Molecules Research(11), Peptidase Inhibition and Analysis(11), Protease and Inhibitor Mechanisms(10), Cancer, Hypoxia, and Metabolism(9)

Publications89 total

Targeting matrix metalloproteinase-14 disrupts DNA repair and reduces viability in adrenocortical carcinoma
2026Open Access
Matrix Metalloproteinase Inhibition in Melanoma
Experimental Dermatology·2026Open Access
Co-inhibition of Notch1 and ChK1 triggers genomic instability and melanoma cell death increasing the lifespan of mice bearing melanoma brain metastasis
Journal of Experimental & Clinical Cancer Research·2025· 1 citedOpen Access
Polyamine acetylation mediates crosstalk between cancer cells and myeloid cells to promote mesenchymal/plurimetabolic states in glioblastoma
Neuro-Oncology·2025· 2 citedOpen Access
Melanoma on Chronically Sun-Damaged Skin: Deciphering Gene Expression Signatures
Dermatology Practical & Conceptual·2025· 1 citedOpen Access
Melanoma on Chronically Sun-Damaged Skin: Deciphering Gene Expression Signatures
Dermatology Practical & Conceptual·2025Open Access
Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME
Journal of Experimental & Clinical Cancer Research·2024· 4 citedOpen Access
Vasoactive Intestinal Peptide Operates as a Negative Regulator of Human Hair Follicle Pigmentation Ex Vivo
Journal of Investigative Dermatology·2024
figure S9 from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
2023Open Access
Figure S10 from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
2023Open Access
Figure S6 from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
2023Open Access
Figure S12 from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
2023Open Access
Figure S8 from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
2023Open Access
Figure S1 from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
2023Open Access
Figure S3 from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
2023Open Access
figure S5 from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
2023Open Access
figure S13 from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
2023Open Access
Figure S11 from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
2023Open Access
figure S5 from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
2023Open Access
Figure S1 from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Renata Colavitti(12), Giovambattista Pani(10), Silvia Borrello(10), Tommaso Galeotti(10), Marianne Broome Powell(9), Amato J. Giaccia(8), Scott M. Welford(8), Keman Zhang(8), Juliano T. Freitas(7), Varsha Thakur(5), Vijay S. Thakur(5), Rosanna Anzevino(4), Poki Wong(4), Jun Ma(4), Bernardetta Palazzotti(3), Olga V. Razorenova(3), Khvaramze Shaverdashvili(3), Iman Osman(3), Barbara Jacobs(3), Ernest C. Borden(3)